KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

KOREA PHARMA Revenue

KOREA PHARMA had revenue of 24.60B KRW in the quarter ending March 31, 2026, with 18.36% growth. This brings the company's revenue in the last twelve months to 91.42B, up 11.78% year-over-year. In the year 2025, KOREA PHARMA had annual revenue of 87.60B with 7.78% growth.

• Revenue (ttm): 91.42B
• Revenue Growth: +11.78%
• P/S Ratio: 1.03
• Revenue / Employee: 682.22M
• Employees: 134
• Market Cap: 94.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.60B	6.32B	7.78%
Dec 31, 2024	81.28B	-1.96B	-2.36%
Dec 31, 2023	83.24B	2.21B	2.73%
Dec 31, 2022	81.03B	1.45B	1.83%
Dec 31, 2021	79.58B	8.07B	11.28%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error